Healthcare provider profile · identity verified

Mark Anthony Angles, M.D.

Internal Medicine · KANSAS CITY, MO · NPI 1568554517

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	344	42
Levothyroxine Sodium	Levothyroxine Sodium	339	42
Potassium Chloride	Potassium Chloride	314	48
Amlodipine Besylate	Amlodipine Besylate	303	48
Lisinopril	Lisinopril	230	31
Eliquis	Apixaban	211	17
Furosemide	Furosemide	203	34
Gabapentin	Gabapentin	196	27
Quetiapine Fumarate	Quetiapine Fumarate	188	16
Pantoprazole Sodium	Pantoprazole Sodium	187	24
Tamsulosin Hcl	Tamsulosin Hcl	185	31
Metformin Hcl	Metformin Hcl	184	19
Omeprazole	Omeprazole	176	24
Metoprolol Succinate	Metoprolol Succinate	173	24
Divalproex Sodium	Divalproex Sodium	162	18
Donepezil Hcl	Donepezil Hcl	146	16
Spironolactone	Spironolactone	139	26
Buspirone Hcl	Buspirone Hcl	137	18
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	135	26
Januvia	Sitagliptin Phosphate	124	suppressed
Sertraline Hcl	Sertraline Hcl	124	16
Metoprolol Tartrate	Metoprolol Tartrate	116	14
Olanzapine	Olanzapine	114	11
Escitalopram Oxalate	Escitalopram Oxalate	110	12
Carvedilol	Carvedilol	107	20
Famotidine	Famotidine	107	12
Jardiance	Empagliflozin	105	suppressed
Trazodone Hcl	Trazodone Hcl	93	15
Mirtazapine	Mirtazapine	92	13
Clopidogrel	Clopidogrel Bisulfate	81	11
Prednisone	Prednisone	80	35
Lorazepam	Lorazepam	76	16
Torsemide	Torsemide	76	15
Xarelto	Rivaroxaban	75	suppressed
Duloxetine Hcl	Duloxetine Hcl	74	11
Memantine Hcl	Memantine Hcl	67	suppressed
Levetiracetam	Levetiracetam	66	suppressed
Lactulose	Lactulose	64	suppressed
Benztropine Mesylate	Benztropine Mesylate	59	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	58	28
Ondansetron Odt	Ondansetron	57	25
Tramadol Hcl	Tramadol Hcl	57	15
Haloperidol	Haloperidol	56	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	56	suppressed
Cephalexin	Cephalexin	54	31
Allopurinol	Allopurinol	52	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	52	suppressed
Losartan Potassium	Losartan Potassium	52	suppressed
Nystop	Nystatin	51	21
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	46	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	45	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	44	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	42	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	39	23
Hydralazine Hcl	Hydralazine Hcl	39	suppressed
Minocycline Hcl	Minocycline Hcl	39	31
Phenytoin Sodium Extended	Phenytoin Sodium Extended	38	suppressed
Warfarin Sodium	Warfarin Sodium	38	suppressed
Baclofen	Baclofen	37	suppressed
Fluticasone Propionate	Fluticasone Propionate	37	suppressed
Meloxicam	Meloxicam	37	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	37	suppressed
Latanoprost	Latanoprost	35	suppressed
Montelukast Sodium	Montelukast Sodium	35	suppressed
Nystatin	Nystatin	35	22
Amitriptyline Hcl	Amitriptyline Hcl	32	suppressed
Haloperidol Decanoate	Haloperidol Decanoate	32	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	32	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	32	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	32	suppressed
Metolazone	Metolazone	32	suppressed
Breo Ellipta	Fluticasone/Vilanterol	31	suppressed
Finasteride	Finasteride	30	suppressed
Humalog	Insulin Lispro	30	suppressed
Simvastatin	Simvastatin	30	suppressed
Divalproex Sodium Er	Divalproex Sodium	29	suppressed
Albuterol Sulfate	Albuterol Sulfate	27	11
Fentanyl	Fentanyl	27	suppressed
Vraylar	Cariprazine Hcl	26	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	26	suppressed
Admelog	Insulin Lispro	25	suppressed
Citalopram Hbr	Citalopram Hydrobromide	25	suppressed
Oxycodone Hcl	Oxycodone Hcl	25	suppressed
Amiodarone Hcl	Amiodarone Hcl	24	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	24	suppressed
Lacosamide	Lacosamide	24	suppressed
Farxiga	Dapagliflozin Propanediol	23	suppressed
Pravastatin Sodium	Pravastatin Sodium	23	suppressed
Amoxicillin	Amoxicillin	22	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	22	suppressed
Insulin Aspart	Insulin Aspart	22	suppressed
Methylprednisolone Acetate	Methylprednisolone Acetate	22	16
Doxazosin Mesylate	Doxazosin Mesylate	21	suppressed
Fenofibrate	Fenofibrate	21	suppressed
Atenolol	Atenolol	20	suppressed
Budesonide	Budesonide	20	suppressed
Humalog Kwikpen U-100	Insulin Lispro	20	suppressed
Levofloxacin	Levofloxacin	20	15
Aripiprazole	Aripiprazole	19	suppressed
Haloperidol Lactate	Haloperidol Lactate	19	suppressed
Estradiol	Estradiol	18	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	18	suppressed
Novolog	Insulin Aspart	18	suppressed
Enulose	Lactulose	17	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	17	suppressed
Levemir Flexpen	Insulin Detemir	17	suppressed
Azithromycin	Azithromycin	16	13
Bupropion Xl	Bupropion Hcl	16	suppressed
Celecoxib	Celecoxib	16	suppressed
Diazepam	Diazepam	16	suppressed
Insulin Lispro	Insulin Lispro	16	suppressed
Levemir	Insulin Detemir	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	suppressed
Alendronate Sodium	Alendronate Sodium	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Prazosin Hcl	Prazosin Hcl	15	suppressed
Risperdal Consta	Risperidone Microspheres	15	suppressed
Sodium Chloride	0.9 % Sodium Chloride	15	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	15	suppressed
Bumetanide	Bumetanide	14	suppressed
Colestipol Hcl	Colestipol Hcl	14	suppressed
Morphine Sulfate Er	Morphine Sulfate	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	suppressed
Risperidone	Risperidone	14	suppressed
Topiramate	Topiramate	14	suppressed
Vancomycin Hcl	Vancomycin/Water For Inj (Peg)	14	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Estradiol (Once Weekly)	Estradiol	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Pregabalin	Pregabalin	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Colesevelam Hcl	Colesevelam Hcl	12	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	12	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Metformin Hcl Er	Metformin Hcl	12	suppressed
Methimazole	Methimazole	12	suppressed
Midodrine Hcl	Midodrine Hcl	12	suppressed
Naproxen	Naproxen	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Oxcarbazepine	Oxcarbazepine	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Phenobarbital	Phenobarbital	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Ranolazine Er	Ranolazine	12	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	12	suppressed
Erythromycin Ethylsuccinate	Erythromycin Ethylsuccinate	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	11	suppressed
Nyamyc	Nystatin	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error